Concepedia

Alvin Wong

AW

Statistics

Publications

50

Citations

5.4K

H-Index

32

Active since

1983

Affiliations

Washington University in St. Louis(Current)

University of California, San Francisco

Hackensack University Medical Center

The University of Texas MD Anderson Cancer Center

Mayo Clinic in Arizona

Alvin Wong is an author at Washington University in St. Louis specializing in medicine, oncology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1983–2023

50

Publications

50

A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

David S. Siegel, Thomas G. Martin, Michael Wang et al. · Blood · 2012 · 654 citations · Full text

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

, , +10

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Arlene Chan, Suzette Delaloge, Frankie A. Holmes et al. · The Lancet Oncology · 2016 · 551 citations

, , +9

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial

Suryanarayan V.S. Deo, Alvin Wong · UNC Libraries · 2020 · 486 citations · Full text

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer

Ahmad Awada, Rámón Colomer, Kenichi Inoue et al. · JAMA Oncology · 2016 · 310 citations · Full text

1–5 of 50